- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.05. | FDA grants RMAT designation to AbelZeta's CAR-T therapy | ||
| 28.05. | 4x the Performance, Zero Compromise: How Functionalized Polymers Are Changing the Rules | ||
| 28.05. | How 3PL providers are gearing up for the wave of cell and gene therapies | ||
| 28.05. | CDC drops Covid-19 vaccine for healthy children and pregnant women | ||
| 28.05. | GlycoEra secures $130m to progress IgG4-targeted protein degrader | ||
| 28.05. | Biogen and City Therapeutics to develop RNAi therapy | ||
| 27.05. | How the cell and gene therapy market is taking shape | ||
| 27.05. | Eli Lilly to expand pain pipeline with $1bn SiteOne buyout | ||
| 27.05. | Capitalising on UK's goal to become a world-leading clinical trial destination | ||
| 27.05. | GSK makes new drug submission for depemokimab in Canada | ||
| 27.05. | What's been agreed at this year's World Health Assembly? | ||
| 27.05. | Lupin partners SteinCares to commercialise biosimilar in LATAM | ||
| 27.05. | FDA to review Otsuka's sibeprenlimab application for IgAN | ||
| 27.05. | Pharmaceutical Technology Excellence Awards 2025: Upperton Pharma Solutions | ||
| 26.05. | China's CDE grants breakthrough status approval to Abbisko's HCC therapy | ||
| 26.05. | CHMP recommends GSK's Blenrep approval for multiple myeloma treatment | ||
| 23.05. | Genentech to onshore US manufacturing amid rising drug pricing tensions | ||
| 23.05. | ASCO25: Roche's Itovebi combo reduces risk of death in breast cancer by 33% | ||
| 23.05. | NICE endorses CSL Vifor's sparsentan for IgA nephropathy in adults | ||
| 23.05. | Obesity therapies and the multi-indication momentum: how industry is responding | ||
| 23.05. | Medicaid on a spit after Republicans' budget bill passes House by single vote | ||
| 23.05. | Bayer's Eylea set for longer treatment intervals to challenge Roche's Vabysmo | ||
| 23.05. | FDA approves GSK's Nucala to treat COPD | ||
| 23.05. | Aptar Digital to use AstraZeneca's AI algorithms for CKD detection | ||
| 22.05. | Paratek expands commercial portfolio with Optinose |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .